The incremental predictive value of arterial stiffness over SCORE2 in the setting of primary cardiovascular prevention: a 6-year follow-up study.

IF 3.3 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE
Ignatios Ikonomidis, John Thymis, Georgios Georgiopoulos, George Pavlidis, Konstantinos Katogiannis, Gavriella Kostelli, Dimitrios Vlastos, Panagiotis Plotas, Helen Triantafyllidi, Dimitrios Delialis, Georgios Mavraganis, Vaia Lambadiari, Kimon Stamatelopoulos
{"title":"The incremental predictive value of arterial stiffness over SCORE2 in the setting of primary cardiovascular prevention: a 6-year follow-up study.","authors":"Ignatios Ikonomidis, John Thymis, Georgios Georgiopoulos, George Pavlidis, Konstantinos Katogiannis, Gavriella Kostelli, Dimitrios Vlastos, Panagiotis Plotas, Helen Triantafyllidi, Dimitrios Delialis, Georgios Mavraganis, Vaia Lambadiari, Kimon Stamatelopoulos","doi":"10.1097/HJH.0000000000003897","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Arterial stiffness hallmarks age-related cardiovascular diseases, precedes their onset and strongly links to accelerated disease progression. However, whether carotid-to-femoral pulse wave velocity (PWV), a proxy of arterial stiffness, predicts cardiovascular risk over and above SCORE2, a newly introduced risk score remains to be investigated.</p><p><strong>Methods: </strong>We measured PWV among 747 individuals without established atheromatosis. Study participants were followed up over a 6-year period for the incidence of cardiovascular events [[MACE)-cardiovascular mortality, stroke and myocardial infarction].</p><p><strong>Results: </strong>PWV emerged as an independent and additive predictor of first cardiovascular events when added in a model encompassing SCORE2 (hazard ratio = 1.10; 95% confidence interval (95% CI) = 1.07-1.14; P < 0.001, Brier score changed from 0.073 (0.060-0.086) to 0.067 (0.055-0.081); P < 0.001, c-statistic increased from 0.71 to 0.75; P = 0.017; likelihood ratio: 20.22; P < 0.001; the overall net reclassification improvement (NRI): 0.577; P < 0.001, AICc changed from 697.81 to 679.60; BIC changed from 702.42 to 688.82]. An increase in PWV predicted a greater risk of future MACEs additively to conventional risk factors (P < 0.05). We performed Kaplan-Meier survival analysis for the tertiles of PWV [first tertile < 8.04 m/s; the second tertile: (8.04-10 m/s); the third tertile: (10-17.10 m/s); (P < 0.05 for all comparisons between the tertiles). PWV tertiles also predicted MACE when added to SCORE2 [for the second tertile: hazard ratio: 5.87 (95% CI: 1.73-19.92); P = 0.004 and for the third tertile: hazard ratio: 9.69 (95% CI: 2.97-31.55); P < 0.001 with the respective change of c-statistic from 0.739 to 0.772; P = 0.012 and continuous NRI = 0.598].</p><p><strong>Conclusion: </strong>PWV confers additive prognostic value to the newly introduced SCORE2 for adverse outcome in primary prevention.</p>","PeriodicalId":16043,"journal":{"name":"Journal of Hypertension","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HJH.0000000000003897","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Arterial stiffness hallmarks age-related cardiovascular diseases, precedes their onset and strongly links to accelerated disease progression. However, whether carotid-to-femoral pulse wave velocity (PWV), a proxy of arterial stiffness, predicts cardiovascular risk over and above SCORE2, a newly introduced risk score remains to be investigated.

Methods: We measured PWV among 747 individuals without established atheromatosis. Study participants were followed up over a 6-year period for the incidence of cardiovascular events [[MACE)-cardiovascular mortality, stroke and myocardial infarction].

Results: PWV emerged as an independent and additive predictor of first cardiovascular events when added in a model encompassing SCORE2 (hazard ratio = 1.10; 95% confidence interval (95% CI) = 1.07-1.14; P < 0.001, Brier score changed from 0.073 (0.060-0.086) to 0.067 (0.055-0.081); P < 0.001, c-statistic increased from 0.71 to 0.75; P = 0.017; likelihood ratio: 20.22; P < 0.001; the overall net reclassification improvement (NRI): 0.577; P < 0.001, AICc changed from 697.81 to 679.60; BIC changed from 702.42 to 688.82]. An increase in PWV predicted a greater risk of future MACEs additively to conventional risk factors (P < 0.05). We performed Kaplan-Meier survival analysis for the tertiles of PWV [first tertile < 8.04 m/s; the second tertile: (8.04-10 m/s); the third tertile: (10-17.10 m/s); (P < 0.05 for all comparisons between the tertiles). PWV tertiles also predicted MACE when added to SCORE2 [for the second tertile: hazard ratio: 5.87 (95% CI: 1.73-19.92); P = 0.004 and for the third tertile: hazard ratio: 9.69 (95% CI: 2.97-31.55); P < 0.001 with the respective change of c-statistic from 0.739 to 0.772; P = 0.012 and continuous NRI = 0.598].

Conclusion: PWV confers additive prognostic value to the newly introduced SCORE2 for adverse outcome in primary prevention.

在心血管疾病一级预防中,动脉僵化比 SCORE2 更具预测价值:一项为期 6 年的随访研究。
目的:动脉僵化是与年龄有关的心血管疾病的特征,它先于疾病的发生,并与疾病的加速进展密切相关。然而,颈动脉到股动脉的脉搏波速度(PWV)作为动脉僵化的替代指标,其预测心血管风险的能力是否超过新引入的风险评分 SCORE2,仍有待研究:我们测量了 747 名未患动脉粥样硬化症的人的脉搏波速度。方法:我们测量了 747 名未确诊动脉粥样硬化的人的脉搏波速度,并对参与者进行了为期 6 年的心血管事件[[MACE]-心血管死亡率、中风和心肌梗死]]发病率随访:结果:在包含 SCORE2 的模型中,脉搏波速度成为首次心血管事件的独立和附加预测因子(危险比 = 1.10;95% 置信区间 (95% CI) = 1.07-1.14;P 结论:脉搏波速度是首次心血管事件的附加预测因子:脉搏波速度与新引入的 SCORE2 相比,对一级预防中的不良结局具有额外的预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Hypertension
Journal of Hypertension 医学-外周血管病
CiteScore
7.90
自引率
6.10%
发文量
1389
审稿时长
3 months
期刊介绍: The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信